Integrated Diagnostics (LON:IDHC) Trading Down 7.6% – Here’s What Happened

Integrated Diagnostics Holdings plc (LON:IDHC)’s stock price was down 7.6% during trading on Thursday . The company traded as low as GBX 0.53 and last traded at GBX 0.54. Approximately 1,043,812 shares changed hands during trading, an increase of 625% from the average daily volume of 143,944 shares. The stock had previously closed at GBX 0.58.

Integrated Diagnostics Price Performance

The stock’s 50-day moving average is GBX 0.59 and its 200 day moving average is GBX 0.63. The company has a debt-to-equity ratio of 43.40, a current ratio of 1.53 and a quick ratio of 0.75. The company has a market cap of £3.20 million, a PE ratio of 0.00, a PEG ratio of 7.65 and a beta of 0.36.

About Integrated Diagnostics

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.